These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23011084)

  • 21. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
    Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.
    Zanni MV; Burdo TH; Makimura H; Williams KC; Grinspoon SK
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):385-90. PubMed ID: 22098563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of soluble CD163 and soluble CD14 following antibiotic therapy of patients with acute brucellosis.
    Sun H; Jiang R; Han B; Du X; Ma C; Xu Y; Chen Z; Wang L; Yang S; Lv X; Zhao H; Li X
    J Infect Dev Ctries; 2019 Aug; 13(8):714-719. PubMed ID: 32069255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
    Gao J; Song L; Li D; Peng L; Ding H
    Medicine (Baltimore); 2019 Oct; 98(42):e17416. PubMed ID: 31626097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study.
    Feng L; Zhou X; Su LX; Feng D; Jia YH; Xie LX
    PLoS One; 2012; 7(7):e38400. PubMed ID: 22911680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary soluble CD163 is a putative non-invasive biomarker for primary sclerosing cholangitis.
    Elger T; Fererberger T; Huss M; Sommersberger S; Mester P; Stoeckert P; Gunawan S; Liebisch G; Loibl J; Kandulski A; Müller M; Buechler C; Tews HC
    Exp Mol Pathol; 2024 Jun; 137():104900. PubMed ID: 38729058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
    Davis BH; Zarev PV
    Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
    Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
    J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis.
    Silva RL; Santos MB; Almeida PL; Barros TS; Magalhães L; Cazzaniga RA; Souza PR; Luz NF; França-Costa J; Borges VM; Lima-Junior DS; Lipscomb MW; Duthie MS; Reed SG; Almeida RP; Jesus AR
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005486. PubMed ID: 28355218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.
    Andersen ES; Rødgaard-Hansen S; Moessner B; Christensen PB; Møller HJ; Weis N
    Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):117-22. PubMed ID: 24424890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN; Abildgaard N; Maniecki MB; Møller HJ; Andersen NF
    Eur J Haematol; 2014 Jul; 93(1):41-7. PubMed ID: 24612259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
    Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
    Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of CD163 in monocytes and its soluble form in the plasma is associated with a pro-inflammatory profile in pregnant women with preeclampsia.
    Nunes PR; Romão-Veiga M; Peraçoli JC; Araujo Costa RA; de Oliveira LG; Borges VTM; Peraçoli MT
    Immunol Res; 2019 Jun; 67(2-3):194-201. PubMed ID: 31240481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
    Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
    Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
    Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis.
    Suzuki Y; Shirai M; Asada K; Miwa S; Karayama M; Nakamura Y; Inui N; Shirai T; Hayakawa H; Baba S; Suda T
    Ann Am Thorac Soc; 2017 Jan; 14(1):57-64. PubMed ID: 27684274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated soluble CD163 in gestational diabetes mellitus: secretion from human placenta and adipose tissue.
    Bari MF; Weickert MO; Sivakumar K; James SG; Snead DR; Tan BK; Randeva HS; Bastie CC; Vatish M
    PLoS One; 2014; 9(7):e101327. PubMed ID: 24983948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
    Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
    Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of soluble sCD163 in serum of psoriatic patients is modulated by Goeckerman therapy.
    Kondelkova K; Krejsek J; Borska L; Fiala Z; Hamakova K; Andrys C
    Allergol Immunopathol (Madr); 2013; 41(3):158-62. PubMed ID: 22765877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble CD163.
    Møller HJ
    Scand J Clin Lab Invest; 2012 Feb; 72(1):1-13. PubMed ID: 22060747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.